FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
25/06/2023
Voltar para busca
Dado oficial do USPTO
WUXI VACCINES
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
29/04/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
40, 42
Data de depósito
20/07/2021
Data de registro
28/02/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
28/02/2023
Última transação
29/04/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
16
Localização do titular
CN
Examinador
FLETCHER, TRACY L
Unidade examinadora
M60
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of a stylized representation of a spiral and shaded circle next to four Chinese characters above the wording "WUXI VACCINES".
Titulares e representantes
Titulares
Shanghai Vaccines Co., Ltd.
Representantes
Eric Lamb Frost Brown Todd LLC
Classificação técnica
Classes Nice
Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 40
Custom assembling of materials for others being custom manufacture of pharmaceuticalschemotherapy drugsantibiotic medicinesvaccines by pharmaceutical compounders; custom manufacture of pharmaceuticals medical preparation; customized production service being custom manufacturing of pharmaceuticals; customized production service being custom manufacturing of vaccines; medicinal materials processing being custom manufacture of pharmaceuticals; processing and treatment of chemical reagentscustom production of reagents for scientific or medical research use; processing of pharmaceutical materials for others being processing of medicinal plants and biological organisms; processing of biomedical materials for others being biomanufacturing for others in the nature of manufacturing of pharmaceuticals and vaccines using biological organisms in the manufacturing process; processing of chemical materials for vaccine production being custom manufacture of vaccines
Classe 42
Development of new products for others; development of pharmaceutical preparations and medicines being research and development of new products for others; scientific research; medicine research services; research and development of new products; consulting services in the field of information technology development; biochemical research and analysis; biomedical research service; development of pharmaceutical preparations and medicines being research and development of new products for others; research and development of pharmaceuticals being research and development of new products for others
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/06/2023
FIMP
FINAL DISPOSITION PROCESSED
02/06/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
28/05/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
28/02/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
28/02/2023
GPNX
NOTIFICATION PROCESSED BY IB
21/12/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
13/12/2022
PUBO
PUBLISHED FOR OPPOSITION
13/12/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
29/11/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
23/11/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
23/11/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/11/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
07/11/2022
ALIE
ASSIGNED TO LIE
07/11/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/11/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
07/11/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/11/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/11/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/11/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/11/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
30/09/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
30/09/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
30/09/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
30/09/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
30/09/2022
RFNT
REFUSAL PROCESSED BY IB
13/06/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
24/05/2022
RFRR
REFUSAL PROCESSED BY MPU
24/05/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
15/04/2022
CNRT
NON-FINAL ACTION WRITTEN
14/04/2022
DOCK
ASSIGNED TO EXAMINER
13/04/2022
MAFR
APPLICATION FILING RECEIPT MAILED
25/01/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
21/01/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
20/01/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace WUXI VACCINES ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.